1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382:727-733. DOI: 10.1056/NEJMoa2001017.
2. Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020;12(3):254. https://doi.org/10.3390/v12030254.
3. World Health Organization. WHO Coronavirus (COVID-19) Dashboard; Available from:https://covid19.who.int/.
4. Farahati, M. Psychological consequences of the outbreak of coronavirus in society. Social impact assessment. 2020;1(2): 207-225. [Persian]
5. Ping W, Zheng J, Niu X, Guo C, Zhang J, Yang H, et al. Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic. PloSone. 2020;15(6), e0234850.
6. Guyatt G.H, Feeny D.H and Patrick D.L. Measuring Health-Related Quality of Life. Ann Intern Med. 1993;118(8), 622-629, doi:10.7326/0003-4819-118-8-199304150-00009.
7. Devlin N J, Shah K K, Feng Y, Mulhern B, Van Hout B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Economics. 2018;27(1), 7-22, doi:https://doi.org/10.1002/hec.3564.
8. Marra C A, Woolcott J C, Kopec J A, Shojania K, Offer R, Brazier J E, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine. 2005;60(7), 1571-1582, doi:https://doi.org/10.1016/j.socscimed.2004.08.034.
9. Patrick D.L, Deyo R.A. Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life. Medical Care. 1989; 27(3): p. S217-S232.
10. Brazier J, Deverill M, Green C. A Review of the Use of Health Status Measures in Economic Evaluation. J Health Serv Res Policy. 1999;4(3), 174-184, doi:10.1177/135581969900400310.
11. Guyatt G H, King D R, Feeny D H, Stubbing D, Goldstein R S. Generic and Specific Measurement of Health-Related Quality of Life in a Clinical Trial of Respiratory Rehabilitation. J Clin Epidemiol. 1999;52(3): p. 187-192. doi:https://doi.org/10.1016/S0895-4356(98)00157-7.
12. Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L Value Set for China. Value in Health. 2017;20(4): p. 662-669. doi:https://doi.org/10.1016/j.jval.2016.11.016.
13. Purba FD, Hunfeld J.A.M, Iskandarsyah A, et al. The Indonesian EQ-5D-5L Value Set. Pharmacoeconomics. 2017; 35:1153–1165. https://doi.org/10.1007/s40273-017-0538-9
14. Prosser LA, Hammitt J.K & Keren R. Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children. Pharmacoeconomics . 2007;25, 713–726. https://doi.org/10.2165/00019053-200725090-00001
15. EuroQol Research Foundation. EQ-5D-5L User Guide. 2019.https://euroqol.org/publications/user-guides. Accessed 15 March 2021.
16. Statistics Center of Iran, Population and Housing Censuses.2021.https://www.amar.org.ir/english/Population-and-Housing-Censuses.Accessed 20 March 2021.
17. Shiraz University of Medical Sciences.2021.https://www.sums.ac.ir/R-lL5Osrt.Accessed 16 March 2021.
18. Statistical Center of Iran.(2021).https://www.amar.org.ir/english/Iran-at-a-glance/Iran.Accessed 26 March 2021.
19. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy.1990; 16(3):199-208. doi:https://doi.org/10.1016/0168-8510(90)90421-9.
20. Goudarzi R, Sari A A, Zeraati H, Rashidian A, Mohammad K, Amini S. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran. Value Health Reg Issues.2019;18:170-175. doi:https://doi.org/10.1016/j.vhri.2019.01.007.
21. Zare F, Ameri H, Madadizadeh F, Aghaei MR. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran. diabetes Metab Syndr.2021;15(1):319-324. doi:https://doi.org/10.1016/j.dsx.2021.01.009.
22. Emrani Z, Akbari Sari A, Zeraati H, Olyaeemanesh A, Daroudi R. Health-related quality of life measured using the EQ-5D–5 L: population norms for the capital of Iran. Health Qual Life Outcomes.2020;18:1-8.
23. McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D–5L: South Australian population norms. Health Qual Life Outcomes.2016;14(1):133. doi:10.1186/s12955-016-0537-0.
24. Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Quality of Life Research.2014;23(2):443-447. doi:10.1007/s11136-013-0498-2.
25. Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci.2017;13(1)1:91-200. doi:10.5114/aoms.2015.52126.
26. Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernández G, et al. An EQ-5D-5L value set based on Uruguayan population preferences. Quality of Life Research.2016; 25(2):323-333.
27. Scalone L, Cortesi P A, Ciampichini R, Cesana G, Mantovani LG. Health related quality of life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiol Biostat Public Health. 2015;12(3).
28. Ferreira LN, Pereira LN, da Fé Brás M, Ilchuk K. Quality of life under the COVID-19 quarantine. Quality of Life Research.2021;1-17. doi:10.1007/s11136-020-02724-x.
29. Vu MQ, Tran TTP, Hoang TA, Khuong LQ, Hoang MV. Health-related quality of life of the Vietnamese during the COVID-19 pandemic. PloS one.2020;15(12):e0244170.
30. Epifanio MS, Andrei F, Mancini G, Agostini F, Piombo MA, Spicuzza V, et al. The Impact of COVID-19 Pandemic and Lockdown Measures on Quality of Life among Italian General Population. Journal of Clinical Medicine.2021;10(2):289.
31. Maugeri G, Castrogiovanni P, Battaglia G, Pippi R, D'Agata V, Palma A, et al. The impact of physical activity on psychological health during Covid-19 pandemic in Italy. Heliyon.2020; 6(6): e04315. doi:https://doi.org/10.1016/j.heliyon.2020.e04315.
32. Carriedo A, Cecchini JA, Fernandez-Rio J, Méndez-Giménez A. COVID-19, Psychological Well-being and Physical Activity Levels in Older Adults During the Nationwide Lockdown in Spain. Am J Geriatr Psychiatry. 2020; 28(11): 1146-1155. doi:https://doi.org/10.1016/j.jagp.2020.08.007.
33. Horesh D, Kapel Lev-Ari R, Hasson-Ohayon I. Risk factors for psychological distress during the COVID-19 pandemic in Israel: Loneliness, age, gender, and health status play an important role. Br J Health Psychol.2020; 25(4):925-933. doi:https://doi.org/10.1111/bjhp.12455.
34. Fujikawa A, Suzue T, Jitsunari F, Hirao T. Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan. Environ Health Prev Med.2011;16(1): 25-35.
35. Yang Z, Busschbach J, Liu G, Luo N. EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes.2018:16(1):210. doi:10.1186/s12955-018-1036-2.
36. Yu ST, Chang HY, Yao KP, Lin YH, Hurng BS.Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan. Quality of Life Research.2015; 24(10): 2541-2548.doi:10.1007/s11136-015-0978-7.
37. Saarni SI, Härkänen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al. The Impact of 29 Chronic Conditions on Health-related Quality of Life: A General Population Survey in Finland Using 15D and EQ-5D. Quality of Life Research. 2006;15(8):1403-14.https://doi.org/10.1007/s11136-006-0020-1.
38. König H-H, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, et al. Comparison of Population Health Status in Six European Countries: Results of a Representative Survey Using the EQ-5D Questionnaire. Medical Care. 2009;47(2):255-61.
39. Ahorsu DK, Lin C-Y, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020. https://doi.org/10.1007/s11469-020-00270-8.
40. Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. Development and initial validation of the COVID Stress Scales. J Anxiety Disord. 2020;72:102232.https://doi.org/10.1016/j.janxdis.2020.102232.